Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Review
. 2022 Nov 30;14(12):2652.
doi: 10.3390/pharmaceutics14122652.

Extracellular Vesicle-Based Therapeutics in Neurological Disorders

Yiwen Yuan  1 , Jian Sun  1 , Tongyao You  1 , Weiwei Shen  1 , Wenqing Xu  1 , Qiang Dong  1   2 , Mei Cui  1   2
Affiliations
Review

Extracellular Vesicle-Based Therapeutics in Neurological Disorders

Yiwen Yuan et al. Pharmaceutics. .

Abstract

Neurological diseases remain some of the major causes of death and disability in the world. Few types of drugs and insufficient delivery across the blood-brain barrier limit the treatment of neurological disorders. The past two decades have seen the rapid development of extracellular vesicle-based therapeutics in many fields. As the physiological and pathophysiological roles of extracellular vesicles are recognized in neurological diseases, they have become promising therapeutics and targets for therapeutic interventions. Moreover, advanced nanomedicine technologies have explored the potential of extracellular vesicles as drug delivery systems in neurological diseases. In this review, we discussed the preclinical strategies for extracellular vesicle-based therapeutics in neurological disorders and the struggles involved in their clinical application.

Keywords: drug delivery; extracellular vesicles; mesenchymal stem cells; neurodegenerative diseases; neurological disorders; therapeutics.

PubMed Disclaimer

Conflict of interest statement

The authors declare that they have no conflict of interest.

Figures

Figure 1
Figure 1
Strategies for EV-based therapeutics in neurological diseases. NSCs, neural stem cells; MSCs, mesenchymal stromal cells; DCs, dendritic cells; Mϕ, macrophage; BBB, blood–brain barrier; miRNA, microRNA; EVs, extracellular vesicles.
See this image and copyright information in PMC

References

    1. Feigin V.L., Nichols E., Alam T., Bannick M.S., Beghi E., Blake N., Culpepper W.J., Dorsey E.R., Elbaz A., Ellenbogen R.G. Global, regional, and national burden of neurological disorders, 1990–2016: A systematic analysis for the Global Burden of Disease Study 2016. Lancet Neurol. 2019;18:459–480. doi: 10.1016/S1474-4422(18)30499-X. - DOI - PMC - PubMed
    1. Kalluri R., LeBleu V.S. The biology, function, and biomedical applications of exosomes. Science. 2020;367:eaau6977. doi: 10.1126/science.aau6977. - DOI - PMC - PubMed
    1. Kao C.Y., Papoutsakis E.T. Extracellular vesicles: Exosomes, microparticles, their parts, and their targets to enable their biomanufacturing and clinical applications. Curr. Opin. Biotechnol. 2019;60:89–98. doi: 10.1016/j.copbio.2019.01.005. - DOI - PubMed
    1. Thery C., Witwer K.W., Aikawa E., Alcaraz M.J., Anderson J.D., Andriantsitohaina R., Antoniou A., Arab T., Archer F., Atkin-Smith G.K., et al. Minimal information for studies of extracellular vesicles 2018 (MISEV2018): A position statement of the International Society for Extracellular Vesicles and update of the MISEV2014 guidelines. J. Extracell. Vesicles. 2018;7:1535750. doi: 10.1080/20013078.2018.1535750. - DOI - PMC - PubMed
    1. Cocucci E., Meldolesi J. Ectosomes and exosomes: Shedding the confusion between extracellular vesicles. Trends Cell Biol. 2015;25:364–372. doi: 10.1016/j.tcb.2015.01.004. - DOI - PubMed